89 related articles for article (PubMed ID: 20434910)
1. Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonism.
Harris RN; Stabler RS; Repke DB; Kress JM; Walker KA; Martin RS; Brothers JM; Ilnicka M; Lee SW; Mirzadegan T
Bioorg Med Chem Lett; 2010 Jun; 20(11):3436-40. PubMed ID: 20434910
[TBL] [Abstract][Full Text] [Related]
2. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
4. Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation.
de la Fuente T; Martín-Fontecha M; Sallander J; Benhamú B; Campillo M; Medina RA; Pellissier LP; Claeysen S; Dumuis A; Pardo L; López-Rodríguez ML
J Med Chem; 2010 Feb; 53(3):1357-69. PubMed ID: 20078106
[TBL] [Abstract][Full Text] [Related]
5. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands.
Lee M; Rangisetty JB; Pullagurla MR; Dukat M; Setola V; Roth BL; Glennon RA
Bioorg Med Chem Lett; 2005 Mar; 15(6):1707-11. PubMed ID: 15745826
[TBL] [Abstract][Full Text] [Related]
6. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
[TBL] [Abstract][Full Text] [Related]
7. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
Purohit A; Herrick-Davis K; Teitler M
Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
[TBL] [Abstract][Full Text] [Related]
8. SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling.
Badarau E; Bugno R; Suzenet F; Bojarski AJ; Finaru AL; Guillaumet G
Bioorg Med Chem; 2010 Mar; 18(5):1958-67. PubMed ID: 20138771
[TBL] [Abstract][Full Text] [Related]
9. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
Pauwels PJ; Gouble A; Wurch T
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship of novel conformationally restricted analogues of serotonin as 5-HT6 receptor ligands.
Nirogi RV; Kambhampati R; Kothmirkar P; Konda J; Bandyala TR; Gudla P; Arepalli S; Gangadasari NP; Shinde AK; Deshpande AD; Dwarampudi A; Chindhe AK; Dubey PK
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):443-50. PubMed ID: 21774748
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 5-HT6 receptor ligands based on virtual HTS.
Tasler S; Kraus J; Wuzik A; Müller O; Aschenbrenner A; Cubero E; Pascual R; Quintana-Ruiz JR; Dordal A; Mercè R; Codony X
Bioorg Med Chem Lett; 2007 Nov; 17(22):6224-9. PubMed ID: 17892934
[TBL] [Abstract][Full Text] [Related]
12. Mapping residues in the ligand-binding domain of the 5-HT(3) receptor onto d-tubocurarine structure.
Yan D; Meyer JK; White MM
Mol Pharmacol; 2006 Aug; 70(2):571-8. PubMed ID: 16723497
[TBL] [Abstract][Full Text] [Related]
13. A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands.
Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):3929-31. PubMed ID: 18583130
[TBL] [Abstract][Full Text] [Related]
14. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
[TBL] [Abstract][Full Text] [Related]
15. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787
[TBL] [Abstract][Full Text] [Related]
16. 1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands.
Bernotas R; Lenicek S; Antane S; Zhang GM; Smith D; Coupet J; Harrison B; Schechter LE
Bioorg Med Chem Lett; 2004 Nov; 14(22):5499-502. PubMed ID: 15482912
[TBL] [Abstract][Full Text] [Related]
17. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands.
Chłoń-Rzepa G; Zmudzki P; Zajdel P; Bojarski AJ; Duszyńska B; Nikiforuk A; Tatarczyńska E; Pawłowski M
Bioorg Med Chem; 2007 Aug; 15(15):5239-50. PubMed ID: 17517514
[TBL] [Abstract][Full Text] [Related]
18. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.
Elokdah H; Li D; McFarlane G; Bernotas RC; Robichaud AJ; Magolda RL; Zhang GM; Smith D; Schechter LE
Bioorg Med Chem; 2007 Sep; 15(18):6208-26. PubMed ID: 17624788
[TBL] [Abstract][Full Text] [Related]
19. Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonists.
Subramanian G; Paterlini MG; Larson DL; Portoghese PS; Ferguson DM
J Med Chem; 1998 Nov; 41(24):4777-89. PubMed ID: 9822548
[TBL] [Abstract][Full Text] [Related]
20. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
Haydar SN; Yun H; Andrae PM; Mattes J; Zhang J; Kramer A; Smith DL; Huselton C; Graf R; Aschmies S; Schechter LE; Comery TA; Robichaud AJ
J Med Chem; 2010 Mar; 53(6):2521-7. PubMed ID: 20170099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
